On September 12, Alexis McKee, MD published an article on “EndocrineWeb,” titled “What Is the Peak Time for NPH Insulin?” “Insulin is a lifesaving hormone that is necessary for cells in your body to absorb sugar (glucose). Depending on the type of diabetes mellitus a person has, there can be a complete absence of insulin (type […]
In May, Cynthia Herrick, MD, FACP and collaborators had their study titled, “Associations among social needs, health and healthcare utilization, and desire for navigation services among US Medicaid beneficiaries with type 2 diabetes,” published in “Health and Social Care in the Community.” The study’s intent was to better understand the social needs of Medicaid beneficiaries […]
On February 23, Maria S. Remedi, PhD and collaborators had their findings published in “Diabetes,” titled “ATP-Sensitive Potassium Channels in Hyperinsulinism and Type 2 Diabetes: Inconvenient Paradox or New Paradigm?” The article is meant to assess if adenosine triphosphate-sensitive potassium (KATP) channels are a new and effective way of thinking, in regard to hyperinsulinism and type […]
Irfan Lodhi, associate professor of medicine at the School of Medicine, received a $1.95 million grant from the National Institute of Health for research titled “Mitochondrial dynamics and the control of adipose tissue thermogenesis.” Targeting brown fat function to promote thermogenesis and increase energy expenditure is a promising strategy to treat obesity and the associated […]
On April 1, ReachMD released an interview featuring Alexis McKee, MD in their “Diabetes Discourse” series. The discussion is titled, “Collaborative Goal Setting in Type 2 Diabetes: Tailoring Treatment Plans for Patients.” In the 10-minute interview, McKee discusses communication strategies that can be used to create personalized treatment plans and to improve adherence among patients […]
Kim A. Carmichael, MD published a recent article in the February 2022 issue of Consultant 360 titled, “What Do You Need to Know About GLP-1 Receptors Agonists?” GLP-1 agonists, otherwise known as glucagon-like peptide 1 agonists, are an important class of medications for patients diagnosed with type 2 diabetes. As the author and series editor, […]
On December 14, Jing W. Hughes, MD, PhD and Hughes Lab members had their research titled, “Islet primary cilia motility controls insulin secretion,” published in “bioRxiv.” “Primary cilia are specialized cell-surface organelles that mediate sensory perception and, in contrast to motile cilia and flagella, are thought to lack motility function.” People with type 2 diabetes […]